Compare BBUC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBUC | AORT |
|---|---|---|
| Founded | 2022 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2021 | 1996 |
| Metric | BBUC | AORT |
|---|---|---|
| Price | $34.36 | $38.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $48.76 |
| AVG Volume (30 Days) | 65.0K | ★ 461.3K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $13.95 |
| Revenue Next Year | N/A | $11.16 |
| P/E Ratio | ★ N/A | $181.05 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $22.97 | $21.97 |
| 52 Week High | $38.25 | $48.25 |
| Indicator | BBUC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 45.22 |
| Support Level | $33.95 | $30.24 |
| Resistance Level | $37.44 | $44.29 |
| Average True Range (ATR) | 1.27 | 1.70 |
| MACD | -0.14 | 0.09 |
| Stochastic Oscillator | 13.75 | 63.64 |
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.